BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16679948)

  • 1. Legal and ethical issues relating to use of complementary therapies in pediatric hematology/oncology.
    Cohen MH
    J Pediatr Hematol Oncol; 2006 Mar; 28(3):190-3. PubMed ID: 16679948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary therapies in pediatrics: a legal perspective.
    Cohen MH; Kemper KJ
    Pediatrics; 2005 Mar; 115(3):774-80. PubMed ID: 15741385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric use of complementary and alternative medicine: legal, ethical, and clinical issues in decision-making.
    Gilmour J; Harrison C; Cohen MH; Vohra S
    Pediatrics; 2011 Nov; 128 Suppl 4():S149-54. PubMed ID: 22045856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concluding comments: maximizing good patient care and minimizing potential liability when considering complementary and alternative medicine.
    Gilmour J; Harrison C; Vohra S
    Pediatrics; 2011 Nov; 128 Suppl 4():S206-12. PubMed ID: 22045865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical and legal issues at the interface of complementary and conventional medicine.
    Kerridge IH; McPhee JR
    Med J Aust; 2004 Aug; 181(3):164-6. PubMed ID: 15287837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative medicine in hematology/oncology: benefits, ethical considerations, and controversies.
    Rosenthal DS; Dean-Clower E
    Hematology Am Soc Hematol Educ Program; 2005; ():491-7. PubMed ID: 16304425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical issues in integrative oncology.
    Ben-Arye E; Schiff E; Golan O
    Hematol Oncol Clin North Am; 2008 Aug; 22(4):737-53, x. PubMed ID: 18638699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and alternative therapies in pediatric oncology.
    Sencer SF; Kelly KM
    Pediatr Clin North Am; 2007 Dec; 54(6):1043-60; xiii. PubMed ID: 18061790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric oncologists' views toward the use of complementary and alternative medicine in children with cancer.
    Roth M; Lin J; Kim M; Moody K
    J Pediatr Hematol Oncol; 2009 Mar; 31(3):177-82. PubMed ID: 19262243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospitals and complementary and alternative medicine: managing responsibilities, risk, and potential liability.
    Gilmour J; Harrison C; Asadi L; Cohen MH; Vohra S
    Pediatrics; 2011 Nov; 128 Suppl 4():S193-9. PubMed ID: 22045863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric use of complementary therapies: ethical and policy choices.
    Cohen MH; Kemper KJ; Stevens L; Hashimoto D; Gilmour J
    Pediatrics; 2005 Oct; 116(4):e568-75. PubMed ID: 16199686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary and alternative medicine: longstanding legal obstacles to cutting edge treatment.
    Ruggio M; DeSantis-Then L
    J Health Life Sci Law; 2009 Jul; 2(4):137, 139-70. PubMed ID: 19673180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legal issues in caring for patients with kidney disease by selectively integrating complementary therapies.
    Cohen MH
    Adv Chronic Kidney Dis; 2005 Jul; 12(3):300-11. PubMed ID: 16010645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethics of complementary and alternative medicine use in children.
    Vohra S; Cohen MH
    Pediatr Clin North Am; 2007 Dec; 54(6):875-84; x. PubMed ID: 18061781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informed consent: advising patients and parents about complementary and alternative medicine therapies.
    Gilmour J; Harrison C; Asadi L; Cohen MH; Vohra S
    Pediatrics; 2011 Nov; 128 Suppl 4():S187-92. PubMed ID: 22045862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medicine in pediatric oncology: availability and institutional policies in Canada--a report from the Children's Oncology Group.
    Johnston DL; Nagel K; O'Halloran C; Sencer SF; Kelly KM; Friebert S; Hilden JM; Friedman DL;
    Pediatr Blood Cancer; 2006 Dec; 47(7):955-8. PubMed ID: 16411194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informed consent in complementary and alternative medicine: current status and future needs.
    Monaco GP; Smith G
    Semin Oncol; 2002 Dec; 29(6):601-8. PubMed ID: 12516044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary and alternative medicine in pediatric oncology.
    Post-White J
    J Pediatr Oncol Nurs; 2006; 23(5):244-53. PubMed ID: 16902077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medicine therapies in pediatric oncology patients.
    McLean TW; Kemper KJ
    J Soc Integr Oncol; 2006; 4(1):40-5. PubMed ID: 16737671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and alternative medical therapies used by children with cancer treated at an Italian pediatric oncology unit.
    Clerici CA; Veneroni L; Giacon B; Mariani L; Fossati-Bellani F
    Pediatr Blood Cancer; 2009 Oct; 53(4):599-604. PubMed ID: 19492321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.